{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:20:51Z","timestamp":1772824851550,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["MA 1648\/7-1"],"award-info":[{"award-number":["MA 1648\/7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["MA 1648\/8-1"],"award-info":[{"award-number":["MA 1648\/8-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Carbohydrate Polymers"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.carbpol.2013.03.033","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T19:23:12Z","timestamp":1363375392000},"page":"404-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Carbohydrate plasma expanders for passive tumor targeting: In vitro and in vivo studies"],"prefix":"10.1016","volume":"95","author":[{"given":"Stefan","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrike","family":"Caysa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Kuntsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Kreidewei\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Leimert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"M\u00e4der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carbpol.2013.03.033_bib0005","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/jps.10397","article-title":"Amphiphilic block copolymers for drug delivery","volume":"92","author":"Adams","year":"2003","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0010","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.addr.2009.04.016","article-title":"Intelligent polymeric micelles from functional poly(ethylene glycol)\u2013poly(amino acid) block copolymers","volume":"61","author":"Bae","year":"2009","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-5793(92)80909-Z","article-title":"Interleukin-8, a chemotactic and inflammatory cytokine","volume":"307","author":"Baggiolini","year":"1992","journal-title":"FEBS Letters"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0020","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1002\/jps.21675","article-title":"Enzymatically catalyzed HES conjugation using microbial transglutaminase: Proof of feasibility","volume":"98","author":"Besheer","year":"2009","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jama.1953.02940180026009","article-title":"Clinical evaluation of dextran as a plasma volume expander","volume":"153","author":"Bowman","year":"1953","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/bc00013a001","article-title":"A brief survey of methods for preparing protein conjugates with dyes, haptens and crosslinking reagents","volume":"3","author":"Brinkley","year":"1992","journal-title":"Bioconjugate Chemistry"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0035","first-page":"30","article-title":"Application of Benchtop-magnetic resonance imaging in a nude mouse tumor model","author":"Caysa","year":"2011","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02425053","article-title":"The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study","volume":"20","author":"Collis","year":"1994","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0045","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.biomaterials.2007.12.037","article-title":"Particle size-dependent organ distribution of gold nanoparticles after intravenous administration","volume":"29","author":"De Jong","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0050","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2009.05.007","article-title":"Development of HPMA copolymer\u2013anticancer conjugates: Clinical experience and lessons learnt","volume":"61","author":"Duncan","year":"2009","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/12_037","article-title":"Polymer therapeutics: Polymers as drugs, drug and protein conjugates and gene delivery systems: Past, present and future opportunities","volume":"192","author":"Duncan","year":"2006","journal-title":"Advances in Polymer Science"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jso.2930310402","article-title":"Tumor measurement in the nude mouse","volume":"31","author":"Euhus","year":"1986","journal-title":"Journal of Surgical Oncology"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0065","first-page":"615","article-title":"Studies on hydroxyethyl starch. Part II: Changes of the molecular weight distribution for hydroxyethyl starch types 450\/0.7, 450\/0.5, 450\/0.3, 300\/0.4, 200\/0.7, 200\/0.5, 200\/0.3 and 200\/0.1 after infusion in serum and urine of volunteers","volume":"35","author":"Ferber","year":"1985","journal-title":"Arzneimittel-Forschung"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0070","first-page":"51","article-title":"Determination of molecular masses of proteins in solution: implementation of an HPLC size exclusion chromatography and laser light scattering service in a core laboratory","volume":"10","author":"Folta-Stogniew","year":"1999","journal-title":"Journal of Biomolecular Techniques"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0169-409X(01)00227-7","article-title":"Targeted drug conjugates: Principles and progress","volume":"53","author":"Garnett","year":"2001","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(99)00447-0","article-title":"Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system","volume":"202","author":"Gaur","year":"2000","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1359-6446(04)03276-3","article-title":"Dendrimers and dendritic polymers in drug delivery","volume":"10","author":"Gillies","year":"2005","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0090","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.carbpol.2012.10.036","article-title":"A review of polysaccharide cytotoxic drug conjugates for cancer therapy","volume":"92","author":"Goodarzi","year":"2012","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0095","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/anie.200502113","article-title":"Polymer therapeutics: Concepts and applications","volume":"45","author":"Haag","year":"2006","journal-title":"Angewandte Chemie International Edition"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0100","series-title":"Therapeutic proteins: Strategies to modulate their plasma half-lives","first-page":"117","article-title":"Half-life extension through HESylation","author":"Hey","year":"2011"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0105","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1021\/bm2015027","article-title":"Dual fluorescent HPMA copolymers for passive tumour targeting with pH-sensitive drug release: Synthesis and characterisation of distribution and tumour accumulation in mice by noninvasive multispectral optical imaging","volume":"13","author":"Hoffmann","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0110","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1126\/science.1281554","article-title":"Interleukin-8 as a macrophage-derived mediator of angiogenesis","volume":"258","author":"Koch","year":"1992","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addr.2009.10.004","article-title":"HPMA copolymers: Origins, early developments, present, and future","volume":"62","author":"Kopecek","year":"2010","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/star.19910431006","article-title":"Measurements of the refractive index increment on hydroxyethyl starch as a basis for absolute molecular weight determinations","volume":"43","author":"Kulicke","year":"1991","journal-title":"Starch"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/star.19930451210","article-title":"Characterization of hydroxyethyl starch by polymer analysis for use as a plasma volume expander","volume":"45","author":"Kulicke","year":"1993","journal-title":"Starch"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.addr.2009.12.004","article-title":"HPMA copolymers: 30 years of advances","volume":"62","author":"Lammers","year":"2010","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jphotobiol.2009.11.007","article-title":"Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications","volume":"98","author":"Leblond","year":"2010","journal-title":"Journal of Photochemistry and Photobiology B: Biology"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0140","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005373-196805000-00005","article-title":"Clinical evaluation of a new plasma expander, hydroxyethyl starch","volume":"8","author":"Lee","year":"1968","journal-title":"The Journal of Trauma"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0145","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1399-6576.2005.00668.x","article-title":"Effects of hydroxyethyl starch on hepatic production of cytokines and activation of transcription factors in lipopolysaccharide-administered rats","volume":"49","author":"Lv","year":"2005","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-2571(00)00013-3","article-title":"The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting","volume":"41","author":"Maeda","year":"2001","journal-title":"Advances in Enzyme Regulation"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2010.05.001","article-title":"EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy","volume":"63","author":"Maeda","year":"2011","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0160","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1148\/radiology.217.3.r00dc07841","article-title":"Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: Correlation of MR findings with histologic features and expression of growth factors1","volume":"217","author":"Matsubayashi","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0165","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Research"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0170","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1039\/C1CS15239D","article-title":"Polysaccharides as building blocks for nanotherapeutics","volume":"41","author":"Mizrahy","year":"2012","journal-title":"Chemical Society Reviews"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0175","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1039\/b505345e","article-title":"Water-solvent method for tosylation and mesylation of primary alcohols promoted by KOH and catalytic amines","volume":"7","author":"Morita","year":"2005","journal-title":"Green Chemistry"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2012.04.009","article-title":"Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: A meta-analysis of randomized trials","volume":"144","author":"Navickis","year":"2012","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0185","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1023\/A:1018949109004","article-title":"Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting","volume":"10","author":"Nishikawa","year":"1993","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0190","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2012.01.006","article-title":"Controlled shielding and deshielding of gene delivery polyplexes using hydroxyethyl starch (HES) and alpha-amylase","volume":"159","author":"Noga","year":"2012","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.4 versus Ringer's acetate in severe sepsis","volume":"367","author":"Perner","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2012.02.012","article-title":"Accumulation of nanocarriers in the ovary: A neglected toxicity risk?","volume":"160","author":"Sch\u00e4dlich","year":"2012","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0210","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s11095-011-0426-5","article-title":"How stealthy are PEG-PLA nanoparticles? An NIR in vivo study combined with detailed size measurements","volume":"28","author":"Sch\u00e4dlich","year":"2011","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0169-409X(95)00039-A","article-title":"Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system","volume":"17","author":"Storm","year":"1995","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0220","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1399-6576.2005.00849.x","article-title":"Influence of hydroxyethyl starch on lipopolysaccharide-induced tissue nuclear factor kappa B activation and systemic TNF-\u03b3 expression","volume":"49","author":"Tian","year":"2005","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0225","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0230","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1055\/s-0038-1649964","article-title":"HES 200\/0.5 is not HES 200\/0.5. Influence of the C2\/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics","volume":"74","author":"Treib","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-3659(99)00141-8","article-title":"Polymeric drugs based on conjugates of synthetic and natural macromolecules: I. Synthesis and physico-chemical characterisation","volume":"64","author":"Ulbrich","year":"2000","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0240","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.addr.2009.08.001","article-title":"Polymer therapeutics: Clinical applications and challenges for development","volume":"61","author":"Vicent","year":"2009","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0245","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1213\/01.ane.0000258224.44806.dd","article-title":"The pros and cons of hydroxyethyl starch solutions","volume":"104","author":"Vincent","year":"2007","journal-title":"Anesthesia & Analgesia"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0250","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/86684","article-title":"A clearer vision for in vivo imaging","volume":"19","author":"Weissleder","year":"2001","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0255","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2012.05.049","article-title":"Comparison of in vitro and in vivo protein release from hydrogel systems","volume":"162","author":"W\u00f6hl-Bruhn","year":"2012","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0260","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejpb.2012.04.017","article-title":"Hydroxyethylstarch-based polymers for the controlled release of biomacromolecules from hydrogel microspheres","volume":"81","author":"W\u00f6hl-Bruhn","year":"2012","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.carbpol.2013.03.033_bib0265","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/star.19840360706","article-title":"A study of hydroxyethyl starch. Long pursuit of hydroxyethyl starch after consecutive infusions into rabbits","volume":"36","author":"Yoshida","year":"1984","journal-title":"Starch"}],"container-title":["Carbohydrate Polymers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861713002713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861713002713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T01:10:06Z","timestamp":1562807406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0144861713002713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0144861713002713"],"URL":"https:\/\/doi.org\/10.1016\/j.carbpol.2013.03.033","relation":{},"ISSN":["0144-8617"],"issn-type":[{"value":"0144-8617","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbohydrate plasma expanders for passive tumor targeting: In vitro and in vivo studies","name":"articletitle","label":"Article Title"},{"value":"Carbohydrate Polymers","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carbpol.2013.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}